Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

27.63 -0.06 (-0.22%)

Streaming Delayed Price Updated: 12:02 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amphastar Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Exploring growth characteristics of AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH). ↗

November 21, 2023

Why AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) qualifies as a high growth stock.

Via Chartmill

Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

November 20, 2023

Via ACCESSWIRE

Evaluating NASDAQ:AMPH for Growth Investment Opportunities. ↗

November 14, 2023

High growth, ROE and relative strength for AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH), growth investors may appreciate this.

Via Chartmill

Amphastar Pharmaceuticals Stock Earns Composite Rating Upgrade ↗

November 10, 2023

Amphastar Pharmaceuticals stock saw its IBD SmartSelect Composite Rating rise to 98 Friday, up from 93 the day before.

Via Investor's Business Daily

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

November 09, 2023

Via ACCESSWIRE

7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗

November 09, 2023

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

Via InvestorPlace

Recap: Amphastar Pharma Q3 Earnings ↗

November 08, 2023

Via Benzinga

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023

November 08, 2023

Via ACCESSWIRE

Disney, Twilio, TransDigm, Marathon Digital And Other Big Stocks Moving Higher On Thursday ↗

November 09, 2023

U.S. stocks traded mostly lower, with the Dow Jones falling around 75 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

CRISPR Therapeutics Stock Earns IBD Stock Rating Upgrade ↗

November 08, 2023

On Wednesday, CRISPR Therapeutics stock had its Relative Strength (RS) Rating upgraded to 85, up from 68 a day earlier.

Via Investor's Business Daily

Earnings Preview For Amphastar Pharma ↗

November 07, 2023

Via Benzinga

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023

November 01, 2023

Via ACCESSWIRE

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023

August 08, 2023

Via ACCESSWIRE

Amphastar Pharma: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Apellis Pharmaceuticals Stock Improves With An RS Ratings Over 90 ↗

October 31, 2023

Apellis Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Revolution Medicines Stock Joins Elite Club With RS Ratings Over 90 ↗

October 16, 2023

Revolution Medicines shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Axsome Therapeutics Stock Clears Key Benchmark, Hits 80-Plus RS Rating ↗

September 27, 2023

A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance.

Via Investor's Business Daily

Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes

September 13, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 11, 2023

Via Benzinga

Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 12, 2023

Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.

Via Benzinga

Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes

September 11, 2023

Via ACCESSWIRE

Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference

August 31, 2023

Via ACCESSWIRE

Eli Lilly (LLY) Stock Up Almost 50% Year to Date: Here's Why ↗

August 17, 2023

Eli Lilly and Company (LLY) boasts a solid portfolio of core drugs in diabetes, autoimmune diseases and cancer.

Via Talk Markets

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023

August 02, 2023

Via ACCESSWIRE

Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI from Lilly

June 30, 2023

Via ACCESSWIRE

Promising Small Biotech Amphastar Sees Actionable Pullback

June 28, 2023

Small-cap Amphastar Pharmaceuticals is pulling back from recent highs in an orderly fashion, potentially offering a new entry point after beating Q1 views.

Via MarketBeat

Abcam Stock Earns Relative Strength Rating Upgrade ↗

June 20, 2023

A Relative Strength Rating upgrade for Abcam ADR shows improving technical performance.

Via Investor's Business Daily

Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) Records 52-Week High Tuesday Morning

June 20, 2023

Via Investor Brand Network

FibroGen Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗

June 06, 2023

On Tuesday, FibroGen stock saw a positive improvement to its Relative Strength Rating, rising to 94 from 90 a day earlier.

Via Investor's Business Daily

Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference

May 31, 2023

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.